EUVIMEDEUVIMED entdecken
Crossref

Benzenesulfonamide as a novel, pharmaceutical small molecule inhibitor on Aβ gene expression and oxidative stress in Alzheimer's Wistar rats

Mahshid Hesar Shourkabi, Maryam Ghobeh, Hanieh Jafary

Biochemical and Biophysical Research Communications · 2023

DOI: 10.1016/j.bbrc.2023.06.063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023. Verfasst von Mahshid Hesar Shourkabi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases, Sulfonamides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Islamic Azad University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is the most prevalent acute neurodegenerative disease described by memory loss and other cognitive functions. Benzenesulfonamide, a novel, potent, and small organic molecule, was synthesized to investigate its effects on the levels of oxidative biomarkers (GPx, ROS, and MDA) and expression of beta-amyloid peptides (Aβ40 and Aβ42) in the pathology of AD. The results were compared with the rivastigmine drug. Applying benzenesulfonamide to Alzheimer's-induced Wistar rats showed a significant increase in the level of oxidative biomarkers (GPx, ROS, and MDA) in both the brain and blood serum as well as amyloid-β40 and 42 gene expressions. Therefore, benzenesulfonamide could be considered a novel therapeutic agent against AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeurodegenerative DiseasesSulfonamidesAnimalsRatsAmyloid beta-PeptidesBiomarkersGene ExpressionOxidative StressPeptide FragmentsRats, WistarReactive Oxygen SpeciesBenzenesulfonamides

Stichwörter der Autor:innen

Alzheimer's diseaseAmyloid-βAβ gene expressionBenzenesulfonamideOxidative stress

Substanzen

Amyloid beta-PeptidesBiomarkersPeptide FragmentsReactive Oxygen SpeciesSulfonamidesBenzenesulfonamides

Autor:innen und Institutionen

  • Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
  • Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran. Electronic address: ghobeh@srbiau.ac.ir.

Förderung

  • Islamic Azad University

Zitieren

APA

Hesar Shourkabi, M., Ghobeh, M., & Jafary, H. (2023). Benzenesulfonamide as a novel, pharmaceutical small molecule inhibitor on Aβ gene expression and oxidative stress in Alzheimer's Wistar rats. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.06.063

Vancouver

Hesar Shourkabi M, Ghobeh M, Jafary H. Benzenesulfonamide as a novel, pharmaceutical small molecule inhibitor on Aβ gene expression and oxidative stress in Alzheimer's Wistar rats. Biochemical and Biophysical Research Communications. 2023. doi:10.1016/j.bbrc.2023.06.063

BibTeX
@article{HesarShourkabi2023,
  author = {Hesar Shourkabi, Mahshid and Ghobeh, Maryam and Jafary, Hanieh},
  title = {Benzenesulfonamide as a novel, pharmaceutical small molecule inhibitor on Aβ gene expression and oxidative stress in Alzheimer's Wistar rats},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2023},
  doi = {10.1016/j.bbrc.2023.06.063}
}
Kostenlos starten →